0001418135-23-000030.txt : 20231116 0001418135-23-000030.hdr.sgml : 20231116 20231116171007 ACCESSION NUMBER: 0001418135-23-000030 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231106 FILED AS OF DATE: 20231116 DATE AS OF CHANGE: 20231116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oxender Monique CENTRAL INDEX KEY: 0002000391 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33829 FILM NUMBER: 231415480 MAIL ADDRESS: STREET 1: 53 SOUTH AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Keurig Dr Pepper Inc. CENTRAL INDEX KEY: 0001418135 STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080] IRS NUMBER: 753258232 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 53 SOUTH AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-418-7000 MAIL ADDRESS: STREET 1: 53 SOUTH AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Dr Pepper Snapple Group, Inc. DATE OF NAME CHANGE: 20080108 FORMER COMPANY: FORMER CONFORMED NAME: CSAB Inc. DATE OF NAME CHANGE: 20071109 3 1 wk-form3_1700172592.xml FORM 3 X0206 3 2023-11-06 0 0001418135 Keurig Dr Pepper Inc. KDP 0002000391 Oxender Monique 53 SOUTH AVE. BURLINGTON MA 01803 0 1 0 0 Chief Corp. Affairs Officer Common Stock 50848 D Restricted Stock Unit 0 Common Stock 12431 D Restricted Stock Unit 0 Common Stock 11008 D Restricted Stock Unit 0 Common Stock 2499 D Restricted Stock Unit 0 Common Stock 13684 D Restricted Stock Unit 0 Common Stock 8165 D Restricted Stock Unit 0 Common Stock 8680 D Restricted Stock Unit 0 Common Stock 4350 D Restricted Stock Unit 0 Common Stock 11517 D Subject to certain vesting conditions and exceptions, these restricted stock units vest in three installments as follows: 60% on March 1, 2026; 20% on March 1, 2027, and 20% on March 1, 2028. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. Subject to certain vesting conditions and exceptions, these restricted stock units vest in three installments as follows: 60% on March 2, 2025; 20% on March 2, 2026, and 20% on March 2, 2027. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. Subject to certain vesting conditions and exceptions, these restricted stock units vest in three installments as follows: 60% on September 14, 2024; 20% on September 14, 2025, and 20% on September 14, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. Represents matching restricted stock units ("Matching RSUs") granted to the Reporting Person in connection with the Issuer's Elite Investment Program. These Matching RSUs vest on September May 26, 2026 ("Vesting Date"), subject to continued service with the Issuer and other vesting conditions. In addition, all or a portion of the Matching RSUs may be forfeited by the Reporting Person if specified stock ownership requirements are not maintained to the Vesting Date. Each Matching RSU represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. Subject to certain vesting conditions and exceptions, these restricted stock units vest in three installments as follows: 60% on March 3, 2024; 20% on March 3, 2025, and 20% on March 3, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. Subject to certain vesting conditions and exceptions, these restricted stock units vest in two equal installments as follows: 50% on September 15, 2024, and 50% on September 15, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. Subject to certain vesting conditions and exceptions, these restricted stock units vest in two equal installments as follows: 50% on March 12, 2024, and 50% on March 12, 2025. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. Subject to certain vesting conditions and exceptions, these restricted stock units vest in full on March 24, 2024. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. /s/ Mark Jackson, attorney in fact 2023-11-16 EX-24 2 oxendermonique_kdplimitedp.htm EX-24 Document

LIMITED POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints each of Anthony Shoemaker, Mark Jackson and Jamie Friesen, or any of them acting singly and with full power of substitution, as the undersigned’s true and lawful attorney-in-fact to:
(1)    Prepare and file with the Securities & Exchange Commission (SEC) an Application for Edgar Access (Form ID) for the undersigned and any forms of filings to be made with the SEC to register the undersigned as an electronic filer;
(2)    execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director, and/or ten percent stockholder of Keurig Dr Pepper Inc. (the Company), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder, as amended from time to time;
(3)    do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, including a Form ID, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority;
(4)    take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-facts sole discretion; and
(5)    seek or obtain, as the undersigned’s representative and on the undersigned’s behalf, information on transactions in the Company’s securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information.
The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-facts substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.



In consideration of the attorney-in-fact acting on the undersigned’s behalf pursuant to this Power of Attorney, the undersigned hereby agrees to indemnify and hold harmless such attorney-in-fact, each substitute attorney-in-fact, and each of their respective heirs, executors, legal representatives, successors, and assigns from and against the entirety of any and all losses, claims, causes of action, damages, fines, defense costs, amounts paid in settlement, liabilities, and expenses, including reasonable attorney’s fees and expenses (collectively, Losses), relating to or arising out of the exercise of this Power of Attorney by such attorney-in-fact or substitute attorney-in-fact, and will reimburse each such indemnified person for all Losses as they are incurred by such indemnified person in connection with any pending or threatened claim, action, suit, proceeding, or investigation with which such indemnified person is or is threatened to be made a party. The undersigned will not, however, be responsible for any losses that are finally determined by a court of competent jurisdiction to have resulted solely from such attorney-in-facts or substitute attorney-in-facts bad faith or willful misconduct.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the 1st day of November, 2023.


By: /s/ Monique Oxender            
Name: Monique Oxender